These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4187888)

  • 1. [Results of very high cyclophosphamide dosage in 42 patients with solid and lymphoreticular tumors].
    Schubert JC; Ischer M; Hilbert L
    Dtsch Med Wochenschr; 1969 Dec; 94(50):2583-8 passim. PubMed ID: 4187888
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity.
    DeWys WD; Goldin A; Man ; El N
    Cancer Res; 1970 Jun; 30(6):1692-7. PubMed ID: 5457936
    [No Abstract]   [Full Text] [Related]  

  • 3. [Course of hematotoxic cyclophosphamide effects in the rat].
    Werner W; Haller M; Höpfner V; Küchler J; Ziervogel J
    Exp Pathol (Jena); 1971; 5(1):123-7. PubMed ID: 5098036
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide toxicity in Ugandan and American patients with malignant lymphoma.
    Brown CH; Ziegler JL; Templeton C; Carbone PP
    Cancer; 1970 Aug; 26(2):462-7. PubMed ID: 5451221
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
    Berger J
    Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide in the treatment of myelomatosis.
    Choi OS; English A; Hilton JH; Catton GE; Brown MD
    Can Med Assoc J; 1967 Nov; 97(19):1133-9. PubMed ID: 4168247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy of autologous preserved marrow on patients undergoing myelodepressive therapeutic treatment].
    Polese E; Massenti S; Rossi-Torelli M
    Minerva Med; 1970 Sep; 61(77):4159-62. PubMed ID: 4921987
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow composition in the adult rhesus monkey (Macaca mulatta).
    Switzer JW
    J Am Vet Med Assoc; 1967 Oct; 151(7):823-9. PubMed ID: 4964823
    [No Abstract]   [Full Text] [Related]  

  • 10. [The state of hemopoiesis in the regional perfusion of malignant tumors of the extremities with sarcolysin, thio-TEPA and cyclophosphane].
    Levin AO; Babinina VF
    Vopr Onkol; 1967; 13(2):48-54. PubMed ID: 4971006
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic recovery after a single high dose of cyclophosphamide in the mouse.
    Scaro JL; Barrio Rendo ME; Alvarez Prado de AR
    Acta Physiol Lat Am; 1972; 22(4):258-65. PubMed ID: 4664105
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atypical paraproteinoses].
    Meiser J; Huhnstock K
    Verh Dtsch Ges Inn Med; 1967; 73():821-4. PubMed ID: 4173596
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.
    Storb R; Buckner CD; Dillingham LA; Thomas ED
    Cancer Res; 1970 Aug; 30(8):2195-203. PubMed ID: 4990004
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of nandrolone phenylpropionate (Durabolin) on the bone-marrow suppression caused by cyclophosphamide.
    Cooke WM; Burn JI
    Br J Surg; 1971 Apr; 58(4):302-3. PubMed ID: 4929363
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphological pattern of bone marrow in patients with tetanus].
    Okulski J
    Pol Tyg Lek; 1969 Oct; 24(47):1802-4. PubMed ID: 5363087
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the immune reaction and its relations with the hematological changes in radiation protected and bone-marrow-treated rats].
    Dimitrov L; Nedelkova M
    Strahlentherapie; 1968 Jun; 135(6):718-23. PubMed ID: 5682139
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chromosome lesions caused by cyclophosphane in the bone marrow cells of a female aplastic anemia patient in the process of preparation for an allogeneic bone marrow transplant].
    Piatkin EK; Baranov AE
    Probl Gematol Pereliv Krovi; 1977 Mar; 22(3):12-6. PubMed ID: 323843
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery of haemopoiesis after cyclophosphamide.
    Kaul M; Hudson G
    Acta Haematol; 1969; 41(3):170-9. PubMed ID: 4978974
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener's granulomatosis.
    Dale DC; Fauci AS; Wolff SM
    Arthritis Rheum; 1973; 16(5):657-64. PubMed ID: 4742843
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of cyclophosphamide on the blood and bone marrow of the guinea-pig.
    Kaul M; Hudson G
    J Anat; 1969 Jan; 104(Pt 1):190. PubMed ID: 5779563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.